Artwork

Вміст надано ChristianaCare. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією ChristianaCare або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !

Patient-Centered Gene Editing with Eric Kmiec, Ph.D.

15:39
 
Поширити
 

Manage episode 424665153 series 3482850
Вміст надано ChristianaCare. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією ChristianaCare або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

This past week the FDA for the first time approved use of a gene editing-based therapy. The new treatment is for people with Sickle Cell Disease. Gene editing has the potential to transform so many areas of medicine. ChristianaCare's Gene Editing Institute is the only institute of its kind in the nation at a community-based health system, which has led GEI to take a unique approach to gene editing research.
On this week's episode, we talk with Eric Kmiec, Ph.D., Executive Director and Chief Scientific Officer at ChristianaCare's Gene Editing Institute, about the patient-centered approach his researchers take. We find out what factors the team considers first when determining what to study and learn what that means for the development of new medicines to treat cancer and inherited diseases.
Join us for a great conversation on the past, present and future of gene editing - what is working, what is not, what opportunities there are beyond medicine and so much more.
Eric Kmiec, Ph.D., is executive director and chief scientific officer at ChristianaCare's Gene Editing Institute. He is also co-founder and chief scientific officer of CorriXR Therapeutics. Widely recognized for his pioneering work in the fields of molecular medicine and gene editing, Dr. Kmiec has developed CRISPR based genetic therapies for Sickle Cell Disease and Non-Small Cell Lung Cancer. He is also Editor-in-Chief of the journal, Gene and Genome Editing.
Links

Thanks for listening and subscribing! Follow us on Facebook, Instagram, Twitter and LinkedIn.

  continue reading

Розділи

1. Patient-Centered Gene Editing with Eric Kmiec, Ph.D. (00:00:00)

2. Simple explanation of gene editing & CRISPR (00:00:58)

3. Current state of gene editing (00:03:16)

4. Unique, patient-centered approach of GEI (00:05:59)

5. Gene editing with underrepresented populations (00:09:43)

6. Future of gene editing (00:11:54)

37 епізодів

Artwork
iconПоширити
 
Manage episode 424665153 series 3482850
Вміст надано ChristianaCare. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією ChristianaCare або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

This past week the FDA for the first time approved use of a gene editing-based therapy. The new treatment is for people with Sickle Cell Disease. Gene editing has the potential to transform so many areas of medicine. ChristianaCare's Gene Editing Institute is the only institute of its kind in the nation at a community-based health system, which has led GEI to take a unique approach to gene editing research.
On this week's episode, we talk with Eric Kmiec, Ph.D., Executive Director and Chief Scientific Officer at ChristianaCare's Gene Editing Institute, about the patient-centered approach his researchers take. We find out what factors the team considers first when determining what to study and learn what that means for the development of new medicines to treat cancer and inherited diseases.
Join us for a great conversation on the past, present and future of gene editing - what is working, what is not, what opportunities there are beyond medicine and so much more.
Eric Kmiec, Ph.D., is executive director and chief scientific officer at ChristianaCare's Gene Editing Institute. He is also co-founder and chief scientific officer of CorriXR Therapeutics. Widely recognized for his pioneering work in the fields of molecular medicine and gene editing, Dr. Kmiec has developed CRISPR based genetic therapies for Sickle Cell Disease and Non-Small Cell Lung Cancer. He is also Editor-in-Chief of the journal, Gene and Genome Editing.
Links

Thanks for listening and subscribing! Follow us on Facebook, Instagram, Twitter and LinkedIn.

  continue reading

Розділи

1. Patient-Centered Gene Editing with Eric Kmiec, Ph.D. (00:00:00)

2. Simple explanation of gene editing & CRISPR (00:00:58)

3. Current state of gene editing (00:03:16)

4. Unique, patient-centered approach of GEI (00:05:59)

5. Gene editing with underrepresented populations (00:09:43)

6. Future of gene editing (00:11:54)

37 епізодів

Усі епізоди

×
 
Loading …

Ласкаво просимо до Player FM!

Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.

 

Короткий довідник